General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Operating Activities:        
Net loss $ (6,722,532) $ (2,968,585) $ (7,266,553) $ (4,274,105)
Adjustments to reconcile net loss to net cash used in operating activities:        
Share-based compensation 3,456,593 1,206,737 2,533,245 1,301,402
Change in fair value of derivative liability 1,180,723 (5,900)
Financing costs 171,739 643,481
Gain on debt extinguishment, net (651,574) 552,871 977,203 455,975
Amortization of debt discount 747,623 93,024 418,339 404,041
Loss on conversion of series A preferred     217,106
Depreciation and amortization 10,494 10,668 21,512 21,301
Effect of changes in assets and liabilities:        
Accounts payable, accrued expenses, and accrued interest (67,693) 317,330 799,144 456,774
Accounts receivable 8,468 8,468 (8,417)
Other assets (8,031) 6,963 7,256 (16,036)
Prepaid expenses (6,737) (22,230) (30,038) 55,052
Net cash used in operating activities (1,889,395) (794,754) (1,676,737) (1,604,013)
Investing Activities:        
Purchase of property and equipment     (2,494)
Other    
Net cash used in investing activities     (2,494)
Financing Activities:        
Proceeds from convertible note payable 130,000 100,000 813,000
Proceeds from sale of common stock 2,978,500 450,000 796,000 1,524,030
Proceeds from series A preferred stock 255,000 555,000
Proceeds from exercise of put option 1,000,000 50,000  
Redemption of series A preferred     (543,465)
Proceeds from note payable     80,000
Proceeds from notes payable - related parties     92,446
Payment of notes payable - related parties     (10,000)
Repurchase common stock (20,000) (166,226)
Proceeds from option exercise 34,133    
Proceeds from warrant exercise 22,000    
Payment of convertible notes payable (845,000)    
Net cash provided by financing activities 3,299,633 805,000 1,670,535 1,520,250
Net change in cash 1,410,238 10,246 (6,202) (86,257)
Cash - beginning of period 10,560 16,762 16,762 103,019
Cash - end of period 1,420,798 27,008 10,560 16,762
Supplemental disclosures of cash flow information:        
Cash paid for interest 314,066 326,221 129,869
Cash paid for income taxes 800 1,600 800
Supplemental disclosure of non-cash investing and financing activities:        
Fair value of derivative liability from issuance of convertible debt and warrant features 301,739 1,256,481
Fair value of warrants issued and beneficial conversion feature to extinguish debt     860,601
Conversion of series A Preferred to common stock     303,641
Fair value of common shares, warrants and beneficial conversion feature of issued convertible note     154,350
Conversion of note payable to common stock 2,277,299 110,880 181,845
Common stock issued to settle accounts payable 100,000 56,000
Conversion of accrued interest on notes payable to related parties note     10,900
Conversion of accrued payroll to related party note     121,875
Conversion of accrued interest on notes payable to convertible notes payable     80,268
Common stock issued to settle accrued officers salary 582,333 $ 180,686
Conversion of notes payable to convertible notes payable $ 56,000